HYPR
Hyperfine, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.80
−0.35%Price chart
Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15
Key dataSep 15, 2026
Open$0.82
From 52W high−63.58%
Volume273905.00
Market cap$84.97M
P/E (TTM)—
P/S (TTM)5.1x
Div yield—
Key dataSep 15, 2026
Open
$0.82
From 52W high
−63.58%
Volume
273905.00
Market cap
$84.97M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.7x
P/E (TTM)
—
RSI (14)
35.0
MomentumView details →
1D Return
−0.35%
YTD Return
−17.91%
SummaryUpdated Jun 1, 2026
Hyperfine, Inc. (NASDAQ:HYPR) is a medical device company founded in 2014 and based in Guilford, Connecticut. The company went public in January 2021 through a SPAC merger. Hyperfine develops and commercializes portable magnetic resonance imaging (MRI) technology, with its flagship product being the Swoop Portable MR imaging system. The company represents a pioneering effort to make MRI technology more accessible by creating a portable, point-of-care solution that can be deployed in various healthcare settings beyond traditional hospital radiology departments.
Similar companies
Latest newsMore news →
MedtechWOMEN named Maria Sainz, President and CEO of Hyperfine, Inc., the winner of its 2026 Ferolyn Powell Leadership Award, and Beverly Tang, co-founder and CEO of Starlight Cardiovascular, the recipient of its first-ever Rising Star Award, at the MedtechVISION Annual Conference in Menlo Park, California.42m agoHyperfine announced the publication of peer-reviewed NEURO PMR results and reported over 3,000 office brain MRI scans, supporting the growing use of the Swoop system in neurology practices during the first year of its neurology office launch.21d agoHyperfine announced FDA clearance of its next Optive AI software, enhancing image quality, clinical utility, ease of use, and isotropic imaging capability of the Swoop system across care settings.27d ago